Log in to save to my catalogue

Molecular mechanisms of cisplatin resistance

Molecular mechanisms of cisplatin resistance

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1014101377

Molecular mechanisms of cisplatin resistance

About this item

Full title

Molecular mechanisms of cisplatin resistance

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2012-04, Vol.31 (15), p.1869-1883

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Platinum-based drugs, and in particular
cis
-diamminedichloroplatinum(II) (best known as cisplatin), are employed for the treatment of a wide array of solid malignancies, including testicular, ovarian, head and neck, colorectal, bladder and lung cancers. Cisplatin exerts anticancer effects via multiple mechanisms, yet its most prominent (and...

Alternative Titles

Full title

Molecular mechanisms of cisplatin resistance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1014101377

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1014101377

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/onc.2011.384

How to access this item